OOIR: Observatory of International Research

Papers

(The TQCC of Allergology International is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
Japanese guidelines for food allergy 2020	141
Japanese guidelines for allergic rhinitis 2020	120
Japanese guidelines for atopic dermatitis 2020	109
Japanese guidelines for adult asthma 2020	93
Mechanisms of allergen-specific immunotherapy and allergen tolerance	93
Subtypes of atopic dermatitis: From phenotype to endotype	89
Innovation in the treatment of atopic dermatitis: Emerging topical and oral Janus kinase inhibitors	61
Epidemiological aspects of allergic conjunctivitis	58
Allergy to COVID-19 vaccines: A current update	57
Skin microbiome of atopic dermatitis	56
Hydrogen sulfide as a novel biomarker of asthma and chronic obstructive pulmonary disease	48
How to detect eosinophil ETosis (EETosis) and extracellular traps	44
IL-24: A new player in the pathogenesis of pro-inflammatory and allergic skin diseases	42
Peripheral itch sensitization in atopic dermatitis	40
The multiple functions and subpopulations of eosinophils in tissues under steady-state and pathological conditions	39
Immune-related adverse events in various organs caused by immune checkpoint inhibitors	38
Japanese guidelines for allergic conjunctival diseases 2020	35
Mechanisms of toxicity mediated by neutrophil and eosinophil granule proteins	32
Skin barrier defects in atopic dermatitis: From old idea to new opportunity	31
Slow low-dose oral immunotherapy: Threshold and immunological change	31
Eosinophils: Cells known for over 140 years with broad and new functions	30
Biologics for severe asthma: The real-world evidence, effectiveness of switching, and prediction factors for the efficacy	28
New medical big data for P4 medicine on allergic conjunctivitis	28
Implications of IL-13Rα2 in atopic skin inflammation	26
Japanese guidelines for childhood asthma 2020	26

Japanese cedar and cypress pollinosis updated: New allergens, cross-reactivity, and treatment	25
Effect of oral immunotherapy in children with milk allergy: The ORIMA study	23
Gut microbiota and allergic diseases in children	22
Hyper-IgE syndrome, 2021 update	21
Role of intracellular zinc in molecular and cellular function in allergic inflammatory diseases	21
Chronic urticaria and the pathogenic role of mast cells	20
Ocular allergy test and biomarkers on the ocular surface: Clinical test for evaluating the ocular surface condition in allergic conjunctival diseases	20
Screening and diagnosis of acute and chronic bird-related hypersensitivity pneumonitis by serum IgG and IgA antibodies to bird antigens with ImmunoCAP®	19
Early introduction of very small amounts of multiple foods to infants: A randomized trial	19
Exacerbating factors and disease burden in patients with atopic dermatitis	19
Individual characteristics and associated factors of hay fever: A large-scale mHealth study using AllerSearch	18
Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment	18
Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021	18
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiency	17
Identification of peroxidase-1 and beta-glucosidase as cross-reactive wheat allergens in grass pollen-related wheat allergy	16
Neuro-allergology: Mast cell–nerve cross-talk	16
The diagnosis and treatment of hereditary angioedema patients in Japan: A patient reported outcome survey	15
Conventional type 2 lung dendritic cells are potent inducers of follicular helper T cells in the asthmatic lung	15
Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients	15
Comparison of sensitization and prevalence of Japanese cedar pollen and mite-induced perennial allergic rhinitis between 2006 and 2016 in hospital workers in Japan	14
Trained innate lymphoid cells in allergic diseases	14
Drug-induced scleroderma-like lesion	14
Maternal exposure to smoking and infant's wheeze and asthma: Japan Environment and Children's Study	14
Executive summary: Japanese guidelines for allergic rhinitis 2020	14
Dupilumab efficacy and safety in Japanese patients with uncontrolled, moderate-to-severe asthma in the phase 3 LIBERTY ASTHMA QUEST study	14
Cycling therapy with benralizumab and dupilumab for severe eosinophilic asthma with eosinophilic chronic rhinosinusitis and eosinophilic otitis media	14
Serum polyethylene glycol-specific IgE and IgG in patients with hypersensitivity to COVID-19 mRNA vaccines	14
Early benralizumab for eosinophilic myocarditis in eosinophilic granulomatosis with polyangiitis	14
Cough persistence in adults with chronic cough: A 4-year retrospective cohort study	14
Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology?	14
Executive summary: Japanese guidelines for adult asthma (JGL) 2021	13
Respiratory sensitization to insect allergens: Species, components and clinical symptoms	13
Multiplex component-based allergen macroarray test is useful to predict clinical reactivity to tree nuts in children	13
Benralizumab as initial treatment for chronic eosinophilic pneumonia	13
Serum IgG4 as a biomarker reflecting pathophysiology and post-operative recurrence in chronic rhinosinusitis	13
Real-life long-term safety and effectiveness of omalizumab in Japanese pediatric patients with severe allergic asthma: A post-marketing surveillance	12
Thymus and activation-regulated chemokine (TARC/CCL17) predicts decline of pulmonary function in patients with chronic obstructive pulmonary disease	12
The understanding of asthma pathogenesis in the era of precision medicine	12
ORMDL3/GSDMB genotype as a risk factor for early-onset adult asthma is linked to total serum IgE levels but not to allergic sensitization	12
In vivo visualization of eosinophil secretion in eosinophilic granulomatosis with polyangiitis: An ultrastructural study	12
Prevention of IL-6 signaling ameliorates toluene diisocyanate-induced steroid-resistant asthma	12
Impact of the COVID-19 pandemic on asthma exacerbations in children: A multi-center survey using an administrative database in Japan	11
ILC2s in skin disorders	11
Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma	11
Management of hereditary angioedema in Japan: Focus on icatibant for the treatment of acute attacks	11
Direct and indirect action modes of acetylcholine in cholinergic urticaria	11
Biologics for allergy: therapeutic potential for ocular allergic diseases and adverse effects on the eye	11
Strategic Outlook toward 2030: Japan's research for allergy and immunology – Secondary publication	11
Drug allergy and autoimmune diseases	10
The effects of mepolizumab on peripheral circulation and neurological symptoms in eosinophilic granulomatosis with polyangiitis (EGPA) patients	10

Current summary of clinical studies on anti-TSLP antibody, Tezepelumab, in asthma	10
Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case–control and cohort studies	10
Dupilumab-resistant facial erythema - Dermoscopic, histological and clinical findings of three patients	10
Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis	10
Executive summary: Japanese guidelines for allergic conjunctival diseases 2021	10
Treatments of refractory eosinophilic lung diseases with biologics	10
Multi-faceted regulation of IgE production and humoral memory formation	10
Activated steady status and distinctive FcεRI-mediated responsiveness in basophils of atopic dermatitis	9
Neuro-immune crosstalk and food allergy: Focus on enteric neurons and mucosal mast cells	9
Neurodevelopment at 6 years of age in children with atopic dermatitis	9
Cord blood eosinophilia precedes neonatal onset of food-protein-induced enterocolitis syndrome (FPIES)	9
Frailty and muscle weakness in elderly patients with asthma and their association with cumulative lifetime oral corticosteroid exposure	9
Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis	9
Relationship between gut microbiota composition and sensitization to inhaled allergens	9
Combined assessment of serum eosinophil-derived neurotoxin and YKL-40 may identify Asthma-COPD overlap	9
Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population	9
Control of immunity and allergy by steroid hormones	9
Primary and pollen-associated hazelnut allergy in school-aged children in Germany: A birth cohort study	8
Drug allergy and non-HIV immune reconstitution inflammatory syndrome	8
Asthma exacerbation associated with COVID-19 pneumonia	8
Interstitial pneumonitis after COVID-19 vaccination: A report of three cases	8
Time will tell about mast cells: Circadian control of mast cell activation	8
Propolis suppresses cytokine production in activated basophils and basophil-mediated skin and intestinal allergic inflammation in mice	8
Inborn errors of immunity with eosinophilia	8
The efficacy of off-label IL-5-modulating treatment in rare eosinophil-mediated diseases	8
Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress	8
Low-dose oral immunotherapy for walnut allergy with anaphylaxis: Three case reports	8
Periostin is an aggravating factor and predictive biomarker of eosinophilic chronic rhinosinusitis	8
L-type amino acid transporter 1 (LAT1)-specific inhibitor is effective against T cell-mediated nasal hyperresponsiveness	8
Comprehensive hospital-based regional survey of anaphylaxis in Japanese children: Time trends of triggers and adrenaline use	8